APA (7th ed.) Citation

Schotte, R., Villaudy, J., Kedde, M., Pos, W., Wagner, K., Go, D., . . . Spits, H. (2020). 580P AT1412, a patient-derived CD9 antibody promotes tumour immune infiltration and induces tumour rejection. Annals of Oncology, 31, S492. https://doi.org/10.1016/j.annonc.2020.08.694

Chicago Style (17th ed.) Citation

Schotte, R., et al. "580P AT1412, a Patient-derived CD9 Antibody Promotes Tumour Immune Infiltration and Induces Tumour Rejection." Annals of Oncology 31 (2020): S492. https://doi.org/10.1016/j.annonc.2020.08.694.

MLA (9th ed.) Citation

Schotte, R., et al. "580P AT1412, a Patient-derived CD9 Antibody Promotes Tumour Immune Infiltration and Induces Tumour Rejection." Annals of Oncology, vol. 31, 2020, p. S492, https://doi.org/10.1016/j.annonc.2020.08.694.